Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–130
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histological or cytological confirmation of a solid, malignant tumour
At least one measurable or non-measurable site of disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) criteria.
You may not be if
Participation in an investigational drug study within the 21 days prior to therapy or those who have not recovered from the effects of an investigational study drug
Recent major surgery within 4 weeks prior to entry into the study
Clareo Health | AZD1152 in Patients With Advanced Solid Malignancies
